Chen, J.* ; Sathiaseelan, V.* ; Moore, A.D.* ; Tan, S.* ; Chilamakuri, C.S.* ; Roamio Franklin, V.N.* ; Shahsavari, A.* ; Jakwerth, C.A. ; Hake, S.B.* ; Warren, A.J.* ; Mohorianu, I.* ; D'Santos, C.S.* ; Ringshausen, I.*
ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia.
Blood 137, 3629-3640 (2021)
The expression of ZAP-70 in a subset of CLL patients strongly correlates with a more aggressive clinical course, though the exact underlying mechanisms remain elusive. The ability of ZAP-70 to enhance B cell receptor (BCR) signaling, independently of its kinase function, is considered to contribute. Here we employed RNA-sequencing and proteomic analyses of primary cells differing only in their expression of ZAP-70 to further define how ZAP-70 increases aggressiveness of CLL. We identified that ZAP-70 is directly required for cell survival in the absence of an overt BCR signal, which can compensate for ZAP-70 deficiency as an anti-apoptotic signal. In addition, the expression of ZAP-70 regulates the transcription of factors regulating recruitment and activation of T cells, such as CCL3, CCL4 and IL4I1. Quantitative mass spectrometry of double-cross linked ZAP-70 complexes further demonstrated constitutive and direct protein-protein interactions between ZAP-70 and BCR-signaling components. Unexpectedly, ZAP-70 also binds to ribosomal proteins, which is not dependent on, but further increased by BCR-stimulation. Importantly, decreased expression of ZAP-70 significantly reduced MYC-expression and global protein synthesis, providing evidence that ZAP-70 contributes to translational dysregulation in CLL. In conclusion, ZAP-70 constitutively promotes cell survival, microenvironment-interactions and protein synthesis in CLL cells, likely to improve cellular fitness and to further drive disease progression.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
B-cell-receptor; C-myc; Cll; Mutations; Subtype
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 137,
Heft: 26,
Seiten: 3629-3640
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Society of Hematology
Verlagsort
2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Allergy
PSP-Element(e)
G-505400-001
Förderungen
European Cooperation in Science and Technology Action "European Network for Innovative Diagnosis and treatment of Chronic Neutropenias"
Cancer Research UK (CRUK)
Specialist Programme from Blood Cancer UK
UK Medical Research Council
Kay Kendall Leukaemia Fund
Wellcome strategic award
Wellcome
Connor Wright Project
Cambridge National Institute for Health Research Biomedical Research Centre
Kay Kendell Foundation
Copyright
Erfassungsdatum
2021-04-29